Axon Enterprise, Inc. (NASDAQ:AXON) Given Average Rating of “Moderate Buy” by Brokerages

Axon Enterprise, Inc. (NASDAQ:AXON) has been given a consensus rating of “Moderate Buy” by the fourteen research firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $365.38.

A number of research firms have recently weighed in on AXON. Robert W. Baird lifted their price target on Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a report on Tuesday, September 10th. Northland Securities boosted their price target on Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th. Jefferies Financial Group started coverage on Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target on the stock. Bank of America started coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price objective for the company. Finally, JMP Securities raised their target price on shares of Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, September 12th.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $393.29 on Friday. The company has a market cap of $29.72 billion, a P/E ratio of 115.00, a PEG ratio of 10.34 and a beta of 0.94. The business has a 50 day moving average of $348.04 and a two-hundred day moving average of $317.22. Axon Enterprise has a 52 week low of $189.12 and a 52 week high of $393.58. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. The business had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business’s revenue for the quarter was up 34.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.80 EPS. As a group, analysts anticipate that Axon Enterprise will post 1.79 EPS for the current year.

Insider Activity

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total value of $167,863.50. Following the transaction, the director now directly owns 7,379 shares in the company, valued at approximately $2,752,588.37. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total value of $167,863.50. Following the completion of the transaction, the director now directly owns 7,379 shares in the company, valued at $2,752,588.37. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $380.99, for a total transaction of $380,990.00. Following the sale, the director now owns 27,259 shares in the company, valued at approximately $10,385,406.41. The disclosure for this sale can be found here. In the last 90 days, insiders sold 317,981 shares of company stock worth $115,662,734. Insiders own 6.10% of the company’s stock.

Institutional Trading of Axon Enterprise

Hedge funds and other institutional investors have recently modified their holdings of the business. Sanctuary Advisors LLC acquired a new position in Axon Enterprise during the second quarter valued at $836,000. New Century Financial Group LLC acquired a new position in shares of Axon Enterprise in the 2nd quarter valued at about $334,000. Cetera Investment Advisers lifted its position in shares of Axon Enterprise by 11.8% in the second quarter. Cetera Investment Advisers now owns 23,546 shares of the biotechnology company’s stock worth $6,928,000 after purchasing an additional 2,479 shares in the last quarter. Truist Financial Corp boosted its holdings in shares of Axon Enterprise by 53.4% during the second quarter. Truist Financial Corp now owns 6,467 shares of the biotechnology company’s stock worth $1,903,000 after purchasing an additional 2,251 shares during the period. Finally, EP Wealth Advisors LLC grew its position in Axon Enterprise by 18.3% during the second quarter. EP Wealth Advisors LLC now owns 1,577 shares of the biotechnology company’s stock valued at $464,000 after purchasing an additional 244 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.